Ovation Science (CSE:OVAT) President and CEO Terry Howlett joined Steve Darling in the Vancouver office of Proactive Investors to share details of their patented technology Invisicare that will deliver CBD and THC through the skin.
On this edition of NewlyTrading, Terry Howlett, CEO of Ovation Science Inc. (OVAT:CSE) explains the path that led to Ovation's listing... and how his company's skincare expertise is leading to patented medicinal CBD release products that work.
Vancouver, BC – November 15, 2018 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) announces that it has closed its Initial Public Offering of units at $0.30 per unit (the “Units”) pursuant to its final prospectus dated October 26, 2018 (the “Prospectus”).
Skinvisible Pharmaceuticals, Inc. ("Skinvisible"), a research and development company with a patented drug delivery system called Invisicare®, today announces the formation of its Ovation Science, Inc. subsidiary, and the company's definitive license agreement with Lighthouse Strategies...
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) and Skinvisible Pharmaceuticals, Inc. ("Skinvisible"), a research and development company with a patented drug delivery system, today announce they have signed a definitive license agreement for...
